NFKB1 and lupus nephritis: This study showed that variants in numerous genes involved in the TLR/NF-κB signaling axis were associated with lupus nephritis, suggesting that inhibition of these variants could provide therapeutic treatment for lupus nephritis patients who have variants in NF-κB regulatory genes.